Swedish researchers develop new AI computer model to detect lymphatic cancer
In the study, the Lymphoma Artificial Reader System accurately detected 90% of lymphatic cancers
Read More
Tag: lymphoma
Positive profile for Enterome’s lymphoma candidate
EO2463 is an experimental treatment for indolent non-Hodgkin B cell lymphoma
Read More
BMS withdraws Istodax as a treatment for peripheral T-cell lymphoma
Phase III trials did not demonstrate sufficient clinical benefit.
Read More
Ledaga recommended by NICE for rare type of lymphoma
Draft guidance recommends Ledaga for early-stage mycosis fungoides-type cutaneous T-cell lymphoma
Read More
NICE backing for Takeda’s Adcetris for rare lymphoma
Standard of care in untreated systemic anaplastic large cell lymphoma (sALCL) has not changed in several decades
Read More
EU regulators approve Takeda’s Adcetris for sALCL
The decision brings a ‘much needed’ new treatment option to this patient community
Read More
Revlimid gets NICE nod for lymphoma
The decision brings a new option to the market for around 900 patients.
Read More
SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma
Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS in Scotland after cost-regulators rejected funding for the treatment in this setting.
Read More
Poteligeo approved in Europe for Mycosis Fungoides, Sézary Syndrome
Kyowa Hakko Kirin (Kyowa Kirin) has received marketing authorisation Europe for use of Poteligeo to treat Mycosis Fungoides and Sézary Syndrome.
Read More
NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma
The National Institute for Health and Care Excellence has turned down NHS funding for use of Novartis’ CAR-T therapy Kymriah in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Read More
Roche’s Gazyvaro gets NICE nod for high-risk lymphoma patients
Cost regulators for NHS treatments in England and Wales have now recommended funding for Roche’s Gazyvaro for some patients with untreated follicular lymphoma, after the submission of new data by the company.
Read More
Speedy EU, US review for Novartis’ CAR-T therapy Kymriah
Regulators on both sides of the Atlantic are undertaking speedy reviews of Novartis’ CAR-T therapy Kymriah.
Read More
- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
